Nivestym (filgrastim)

pCPA File Number: 21205

Negotiation Status:

Concluded with an LOI

Indication(s):

Prevention or treatment of neutropenia in various indications

Sponsor/Manufacturer:

Pfizer Canada ULC

CADTH Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2020-04-27

Negotiation Process Concluded:

2020-06-17